$CVM
CEL SCI CORP Stock $cvm

$cvm Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000165495424001793 Filed on February 14, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2022 Q4
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.447M	$2.133M	$2.258M
YoY Change	16.95%	-5.52%	-18.19%
% of Gross Profit
Research & Development	$4.629M	$4.353M	$5.393M
YoY Change	-23.92%	-19.29%	-11.35%
% of Gross Profit
Depreciation & Amortization	$988.8K	$1.005M	$988.5K
YoY Change	0.34%	1.63%	11.33%
% of Gross Profit
Operating Expenses	$7.076M	$6.486M	$7.651M
YoY Change	-13.46%	-15.22%	-13.49%
Operating Profit	-$7.076M	-$6.486M	-$7.651M
YoY Change	-13.46%	-15.22%	-13.49%
Interest Expense	-$182.7K	-$197.7K	-$152.8K
YoY Change	14.86%	29.39%	-266.86%
% of Operating Profit
Other Income/Expense, Net	$13.76K	-$25.94K	-$50.17K
YoY Change	-283.47%	-48.3%	62.94%
Pretax Income	-$7.245M	-$6.710M	-$7.854M
YoY Change	-13.16%	-14.57%	-10.58%
Income Tax
% Of Pretax Income
Net Earnings	-$7.245M	-$6.710M	-$7.854M
YoY Change	-13.16%	-14.57%	-10.58%
Net Earnings / Revenue
Basic Earnings Per Share			-$0.18
Diluted Earnings Per Share	-$0.14	-$0.14	-$0.18
COMMON SHARES
Basic Shares Outstanding	50.10M shares	49.98M shares	43.68M shares
Diluted Shares Outstanding			44.44M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.325M	$3.258M	$18.02M
YoY Change	-47.18%	-81.92%	-51.45%
Cash & Equivalents	$5.309M	$3.241M	$18.02M
Short-Term Investments	$16.13K	$16.13K
Other Short-Term Assets	$696.7K	$549.8K	$538.3K
YoY Change	16.42%	2.15%	-79.57%
Inventory	$2.489M	$2.347M	$1.849M
Prepaid Expenses	$696.6K	$549.8K	$538.3K
Receivables
Other Receivables
Total Short-Term Assets	$8.511M	$6.154M	$20.40M
YoY Change	-32.31%	-69.84%	-51.26%
LONG-TERM ASSETS
Property, Plant & Equipment	$9.113M	$9.644M	$11.52M
YoY Change	-18.48%	-16.29%	-13.31%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.393M	$2.394M	$104.6K
YoY Change	-1.17%	2188.08%
Total Long-Term Assets	$21.54M	$22.56M	$24.15M
YoY Change	-15.94%	-6.61%	-13.13%
TOTAL ASSETS
Total Short-Term Assets	$8.511M	$6.154M	$20.40M
Total Long-Term Assets	$21.54M	$22.56M	$24.15M
Total Assets	$30.05M	$28.71M	$44.56M
YoY Change	-21.33%	-35.57%	-36.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.016M	$1.144M	$1.600M
YoY Change	-46.21%	-28.47%	34.12%
Accrued Expenses	$1.219M	$985.7K	$800.8K
YoY Change	14.6%	23.08%	-11.01%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.889M	$1.827M	$1.600M
YoY Change	18.05%	14.21%	166.67%
Total Short-Term Liabilities	$5.087M	$4.867M	$4.742M
YoY Change	-4.23%	2.64%	42.25%
LONG-TERM LIABILITIES
Long-Term Debt	$8.987M	$9.468M	$11.30M
YoY Change	-17.21%	-16.18%	-12.31%
Other Long-Term Liabilities	$125.0K	$125.0K	$125.0K
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Liabilities	$125.0K	$125.0K	$125.0K
YoY Change	0.0%	0.0%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.087M	$4.867M	$4.742M
Total Long-Term Liabilities	$125.0K	$125.0K	$125.0K
Total Liabilities	$15.74M	$16.06M	$17.97M
YoY Change	-12.77%	-10.61%	-1.93%
SHAREHOLDERS EQUITY
Retained Earnings	-$501.0M	-$493.8M	-$462.8M
YoY Change	6.36%	6.71%	8.38%
Common Stock	$540.8K	$500.2K	$437.3K
YoY Change	23.51%	14.39%	1.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$14.30M	$12.65M	$26.59M
YoY Change
Total Liabilities & Shareholders Equity	$30.05M	$28.71M	$44.56M
YoY Change	-21.33%	-35.57%	-36.05%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2022 Q4
OPERATING ACTIVITIES
Net Income	-$7.245M	-$6.710M	-$7.854M
YoY Change	-13.16%	-14.57%	-10.58%
Depreciation, Depletion And Amortization	$988.8K	$1.005M	$988.5K
YoY Change	0.34%	1.63%	11.33%
Cash From Operating Activities	-$4.528M	-$4.888M	-$4.667M
YoY Change	-39.4%	4.74%	-2.9%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$51.65K	$53.58K
YoY Change	-100.0%	-3.6%	214.51%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$13.21K	$0.00
YoY Change			-100.0%
Cash From Investing Activities	$0.00	-$64.86K	-$53.58K
YoY Change	-100.0%	21.05%	-100.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	6.596M	$4.048M	$65.41K
YoY Change	-1798.36%	6089.41%	-125.5%
NET CHANGE
Cash From Operating Activities	-4.528M	-$4.888M	-$4.667M
Cash From Investing Activities	0.000	-$64.86K	-$53.58K
Cash From Financing Activities	6.596M	$4.048M	$65.41K
Net Change In Cash	2.068M	-$904.3K	-$4.655M
YoY Change	-125.94%	-80.57%	-543.41%
FREE CASH FLOW
Cash From Operating Activities	-$4.528M	-$4.888M	-$4.667M
Capital Expenditures	$0.00	$51.65K	$53.58K
Free Cash Flow	-$4.528M	-$4.940M	-$4.720M
YoY Change	-40.29%	4.65%	-2.13%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50018601	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	47422304	shares
CY2023Q4	dei	Entity Central Index Key EntityCentralIndexKey	0000725363
CY2023Q4	dei	Amendment Flag AmendmentFlag	false
CY2023Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2023Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50018601	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47422304	shares
CY2023Q4	cvm	Equity Warrants Exercise Price EquityWarrantsExercisePrice	0
CY2022Q4	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	700000.0	usd
CY2022Q4	us-gaap	Operating Lease Expense OperatingLeaseExpense	100000.0	usd
CY2022Q4	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	100000.0	usd
CY2022Q4	cvm	Patent Impairment Charges PatentImpairmentCharges	0	usd
CY2023Q4	cvm	Patent Impairment Charges PatentImpairmentCharges	0	usd
CY2023Q4	dei	Document Type DocumentType	10-Q
CY2023Q4	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q4	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023Q4	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q4	dei	Entity File Number EntityFileNumber	001-11889
CY2023Q4	dei	Entity Registrant Name EntityRegistrantName	CEL-SCI CORPORATION
CY2023Q4	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
CY2023Q4	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-0916344
CY2023Q4	dei	Entity Address Address Line1 EntityAddressAddressLine1	8229 Boone Boulevard
CY2023Q4	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 802
CY2023Q4	dei	Entity Address City Or Town EntityAddressCityOrTown	Vienna
CY2023Q4	dei	Entity Address State Or Province EntityAddressStateOrProvince	VA
CY2023Q4	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	22182
CY2023Q4	dei	City Area Code CityAreaCode	703
CY2023Q4	dei	Local Phone Number LocalPhoneNumber	506-9460
CY2023Q4	dei	Security12b Title Security12bTitle	Common Stock
CY2023Q4	dei	Trading Symbol TradingSymbol	CVM
CY2023Q4	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2023Q4	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q4	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q4	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q4	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q4	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q4	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	50104231	shares
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3241440	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4145735	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	549835	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	520368	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2347049	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	2248072	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	16129	usd
CY2023Q3	us-gaap	Deposits Assets Current DepositsAssetsCurrent	4245	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	6154453	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	6918420	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	8680732	usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	9131987	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1649020	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1698243	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9644158	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10188126	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	188294	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	197704	usd
CY2023Q4	us-gaap	Deposits Assets DepositsAssets	2319101	usd
CY2023Q3	us-gaap	Deposits Assets DepositsAssets	2319101	usd
CY2023Q4	cvm	Supplies Used For Rd And Manufacturing Non Current SuppliesUsedForRDAndManufacturingNonCurrent	74457	usd
CY2023Q3	cvm	Supplies Used For Rd And Manufacturing Non Current SuppliesUsedForRDAndManufacturingNonCurrent	74669	usd
CY2023Q4	us-gaap	Assets Assets	28710215	usd
CY2023Q3	us-gaap	Assets Assets	30528250	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1144425	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2009786	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	985657	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1049581	usd
CY2023Q4	cvm	Due To Employee Current DueToEmployeeCurrent	705698	usd
CY2023Q3	cvm	Due To Employee Current DueToEmployeeCurrent	557244	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1827363	usd
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1771804	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	204167	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	197431	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4867310	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5585846	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	9468149	usd
CY2023Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	9949565	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1599496	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1652949	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	125000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	125000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	16059955	usd
CY2023Q3	us-gaap	Liabilities Liabilities	17313360	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	500186	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	474223	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	505950994	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	499832063	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-493800920	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-487091396	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	12650260	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	13214890	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	28710215	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30528250	usd
CY2023Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4352509	usd
CY2022Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5392546	usd
CY2023Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2133378	usd
CY2022Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2258003	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	6485887	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	7650549	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-6485887	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-7650549	usd
CY2023Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-197696	usd
CY2022Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-152789	usd
CY2023Q4	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	25941	usd
CY2022Q4	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	50171	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-6709524	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-7853509	usd
CY2023Q4	cvm	Modification Of Warrants ModificationOfWarrants	0	usd
CY2022Q4	cvm	Modification Of Warrants ModificationOfWarrants	-171552	usd
CY2023Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6709524	usd
CY2022Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8025061	usd
CY2023Q4	cvm	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.14
CY2022Q4	cvm	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.18
CY2023Q4	cvm	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	48470600	shares
CY2022Q4	cvm	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	43440387	shares
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	13214890	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	48907	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	202307	usd
CY2023Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4980000	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1383909	usd
CY2023Q4	cvm	Share Issuance Costs ShareIssuanceCosts	-470229	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-6709524	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	12650260	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	32163207	usd
CY2022Q4	cvm	Warrant Exercises Amount WarrantExercisesAmount	447291	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	50178	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	91623	usd
CY2022Q4	cvm	Incentive Stock Forfeited Amount IncentiveStockForfeitedAmount	-11100	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1703931	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-7853509	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	26591621	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-6709524	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-7853509	usd
CY2023Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1004633	usd
CY2022Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	988543	usd
CY2023Q4	us-gaap	Other Noncash Expense OtherNoncashExpense	2504	usd
CY2022Q4	us-gaap	Other Noncash Expense OtherNoncashExpense	5078	usd
CY2023Q4	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	218386	usd
CY2022Q4	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	148858	usd
CY2023Q4	us-gaap	Share Based Compensation ShareBasedCompensation	1383909	usd
CY2022Q4	us-gaap	Share Based Compensation ShareBasedCompensation	1692831	usd
CY2023Q4	cvm	Common Stock Contributed To Employee Benefit Plan CommonStockContributedToEmployeeBenefitPlan	48907	usd
CY2022Q4	cvm	Common Stock Contributed To Employee Benefit Plan CommonStockContributedToEmployeeBenefitPlan	50178	usd
CY2023Q4	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	100546	usd
CY2022Q4	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-111537	usd
CY2023Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	98765	usd
CY2022Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-212687	usd
CY2023Q4	cvm	Increase Decrease In Deposit Assets IncreaseDecreaseInDepositAssets	11884	usd
CY2022Q4	cvm	Increase Decrease In Deposit Assets IncreaseDecreaseInDepositAssets	0	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-765078	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-115285	usd
CY2023Q4	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-8924	usd
CY2022Q4	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	13346	usd
CY2023Q4	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	148454	usd
CY2022Q4	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	79087	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4887928	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4666649	usd
CY2023Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	51650	usd
CY2022Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	53580	usd
CY2023Q4	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	13211	usd
CY2022Q4	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-64861	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-53580	usd
CY2023Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4980000	usd
CY2022Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2023Q4	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	504913	usd
CY2022Q4	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	9010	usd
CY2023Q4	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2022Q4	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	447291	usd
CY2023Q4	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	426593	usd
CY2022Q4	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	372871	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4048494	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	65410	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-904295	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-4654819	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4145735	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22672138	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3241440	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18017319	usd
CY2023Q4	cvm	Property And Equipment Purchases Included In Current Liabilities PropertyAndEquipmentPurchasesIncludedInCurrentLiabilities	0	usd
CY2022Q4	cvm	Property And Equipment Purchases Included In Current Liabilities PropertyAndEquipmentPurchasesIncludedInCurrentLiabilities	105318	usd
CY2023Q4	cvm	Finance Lease Obligation Included In Accounts Payable FinanceLeaseObligationIncludedInAccountsPayable	714	usd
CY2022Q4	cvm	Finance Lease Obligation Included In Accounts Payable FinanceLeaseObligationIncludedInAccountsPayable	1853	usd
CY2023Q4	cvm	Prepaid Consulting Services Paid With Issuance Of Common Stock PrepaidConsultingServicesPaidWithIssuanceOfCommonStock	202307	usd
CY2022Q4	cvm	Prepaid Consulting Services Paid With Issuance Of Common Stock PrepaidConsultingServicesPaidWithIssuanceOfCommonStock	91623	usd
CY2023Q4	cvm	Financing Costs Included In Current Liabilities FinancingCostsIncludedInCurrentLiabilities	43019	usd
CY2022Q4	cvm	Financing Costs Included In Current Liabilities FinancingCostsIncludedInCurrentLiabilities	0	usd
CY2023Q4	us-gaap	Interest Paid Net InterestPaidNet	244659	usd
CY2022Q4	us-gaap	Interest Paid Net InterestPaidNet	277853	usd
CY2023Q4	cvm	Impairment Of Long Lived Assets Policy Textblock ImpairmentOfLongLivedAssetsPolicyTextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;"><em>Impairment of long-lived assets</em> – CEL-SCI’s fixed assets are made up of leasehold improvements, furniture, and equipment. ASC 360-10 requires that a long-lived asset group be reviewed for impairment only when events or changes in circumstances indicate that the carrying amount of the long-lived asset (group) might not be recoverable. CEL-SCI’s recurring losses are a triggering event that could indicate impairment of long-lived assets such as fixed assets. CEL-SCI reviews these assets to determine if events or changes in circumstances indicate the existence of impairment. If indicators of impairment exist, the Company tests for recoverability, then, if necessary, measures and records the impairment. The amount of the impairment loss would be the amount by which the carrying amount of the asset (group) exceeds its fair value.</p>
CY2023Q4	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;"><em>Use of Estimates</em> – The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and the accompanying disclosures. These estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future. Estimates are used in accounting for, among other items, inventory obsolescence, accruals, stock options, useful lives for depreciation and amortization of long-lived assets, right of use assets and lease liabilities, deferred tax assets and the related valuation allowance. Actual results could differ from estimates, although management does not generally believe such differences would materially affect the financial statements in any given year. Additionally, in calculating the right of use assets and lease liabilities, estimates and assumptions were used to determine the incremental borrowing rates and the expected lease terms. The Company considers the estimates used in valuing the stock options and the lease assets and liabilities to be significant. </p>
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2490000	shares
CY2023Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	2.00
CY2023Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5000000.0	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	138400	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2500	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	11000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	96832	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	45400	shares
CY2023Q4	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1383909	usd
CY2022Q4	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1692831	usd
CY2023Q4	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	218386	usd
CY2022Q4	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	148858	usd
CY2023Q4	cvm	Equity Warrants Exercised EquityWarrantsExercised	217752	shares
CY2023Q4	cvm	Proceeds From Equity Warrants Exercised ProceedsFromEquityWarrantsExercised	447291	usd
CY2023Q4	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	35800000	usd
CY2023Q4	cvm	Net Of Discount NetOfDiscount	11900000	usd
CY2023Q4	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	700000	usd
CY2023Q4	us-gaap	Interest Paid InterestPaid	200000	usd
CY2022Q4	us-gaap	Interest Paid InterestPaid	300000	usd
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0844	pure
CY2023Q4	us-gaap	Resale Agreement Counterparty Weighted Average Maturity Of Agreements1 ResaleAgreementCounterpartyWeightedAverageMaturityOfAgreements1	P4Y9M29D
CY2023Q4	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	1995000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	2741000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	2832000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	2923000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	3015000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	252000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	13758000	usd
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	2463000	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	11295000	usd
CY2023Q4	cvm	Finance Lease Liability Current Portion FinanceLeaseLiabilityCurrentPortion	1827000	usd
CY2023Q4	cvm	Finance Lease Liability Noncurrent Portion FinanceLeaseLiabilityNoncurrentPortion	9468000	usd
CY2023Q4	us-gaap	Operating Lease Expense OperatingLeaseExpense	100000	usd
CY2023Q4	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	100000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1019	pure
CY2023Q4	us-gaap	Repurchase Agreement Counterparty Weighted Average Maturity Of Agreements1 RepurchaseAgreementCounterpartyWeightedAverageMaturityOfAgreements1	P7Y8M26D
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	268000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	366000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	287000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	277000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	285000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	294000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	746000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2523000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	720000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1803000	usd
CY2023Q4	cvm	Operating Lease Liability Current Portion OperatingLeaseLiabilityCurrentPortion	204000	usd
CY2023Q4	cvm	Operating Lease Liability Noncurrent Portion OperatingLeaseLiabilityNoncurrentPortion	1599000	usd
CY2023Q4	cvm	Finite Lived Intangible Assets Remaining Amortization Period FiniteLivedIntangibleAssetsRemainingAmortizationPeriod	P8Y
CY2023Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9000	usd
CY2022Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	23000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	29000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	25000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	22000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	19000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	16000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive	54000	usd
CY2023Q4	us-gaap	Other Indefinite Lived Intangible Assets OtherIndefiniteLivedIntangibleAssets	188000	usd
CY2023Q4	cvm	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	-6709524	usd
CY2022Q4	cvm	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	-8025061	usd
CY2023Q4	cvm	Weighted Average Number Of Share Outstanding Basics And Diluted WeightedAverageNumberOfShareOutstandingBasicsAndDiluted	48470600	shares
CY2022Q4	cvm	Weighted Average Number Of Share Outstanding Basics And Diluted WeightedAverageNumberOfShareOutstandingBasicsAndDiluted	43440387	shares
CY2023Q4	cvm	Income Loss From Continuing Operations Per Basic And Diluted Shares IncomeLossFromContinuingOperationsPerBasicAndDilutedShares	-0.14
CY2022Q4	cvm	Income Loss From Continuing Operations Per Basic And Diluted Shares IncomeLossFromContinuingOperationsPerBasicAndDilutedShares	-0.18
CY2023Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15986278	shares
CY2022Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14066602	shares

Files In Submission

Name	View Source	Status
0001654954-24-001793-index-headers.html	Edgar Link	pending
0001654954-24-001793-index.html	Edgar Link	pending
0001654954-24-001793.txt	Edgar Link	pending
0001654954-24-001793-xbrl.zip	Edgar Link	pending
cvm-20231231.xsd	Edgar Link	pending
cvm_10q.htm	Edgar Link	pending
cvm_10qimg15.jpg	Edgar Link	pending
cvm_10qimg16.jpg	Edgar Link	pending
cvm_10qimg17.jpg	Edgar Link	pending
cvm_10qimg18.jpg	Edgar Link	pending
cvm_10qimg19.jpg	Edgar Link	pending
cvm_10qimg20.jpg	Edgar Link	pending
cvm_10qimg21.jpg	Edgar Link	pending
cvm_ex31.htm	Edgar Link	pending
cvm_ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
cvm-20231231_def.xml	Edgar Link	unprocessable
cvm-20231231_lab.xml	Edgar Link	unprocessable
cvm-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cvm_10q_htm.xml	Edgar Link	completed
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cvm-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CVM
CEL SCI CORP Stock $cvm

2024 Q1 Form 10-Q Financial Statement

#000165495424001793 Filed on February 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CVM CEL SCI CORP Stock $cvm

2024 Q1 Form 10-Q Financial Statement

#000165495424001793 Filed on February 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CVM
CEL SCI CORP Stock $cvm